Hair-loss drug boosts hair growth by 539% – Irish study
After decades of limited options for male-pattern baldness, a new topical drug has delivered encouraging results in late-stage…
Cosmo Pharmaceuticals (SWX:COPN) Is Up 46.9% After Expanding Its Clascoterone Dermatology Franchise
Cosmo Pharmaceuticals recently reported successful Phase III results for its Clascoterone 5% solution in male hair loss and…
Cosmo Surges 40% on Baldness Candidate’s Phase III Data
Images of the scalps of two patients treated with the 5% formulation of Cosmo Pharmaceuticals’ androgenetic alopecia (AGA)…